Are B7-H3 CAR-T cells the future universal treatment for pediatric brain tumors?
- PMID: 33755151
- PMCID: PMC8168811
- DOI: 10.1093/neuonc/noab063
Are B7-H3 CAR-T cells the future universal treatment for pediatric brain tumors?
Comment on
-
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.Neuro Oncol. 2021 Jun 1;23(6):999-1011. doi: 10.1093/neuonc/noaa278. Neuro Oncol. 2021. PMID: 33320196 Free PMC article.
References
-
- Haydar D, Houke H, Chiang J, et al. . Cell surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery [published online ahead of print December 15, 2020]. Neuro Oncol. doi:10.1093/neuonc/noaa278. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials